Johnson A A, Tsai Y c, Graves S W, Johnson K A
Institute for Cellular and Molecular Biology, A4800, MBB 3.122, University of Texas at Austin, Austin, Texas 78712, USA.
Biochemistry. 2000 Feb 22;39(7):1702-8. doi: 10.1021/bi992104w.
We have reconstituted the holoenzyme of the human mitochondrial DNA polymerase from cloned and overexpressed catalytic and accessory subunits. We have examined the polymerization activity of the catalytic subunit alone and of the holoenzyme to establish the function of the accessory subunit in this two subunit enzyme. The accessory subunit associates with the catalytic subunit with a dissociation constant of 35 +/- 16 nM as measured by the concentration dependence of its effect in stimulating maximal DNA binding and polymerization. At saturating concentrations, the accessory subunit contributes to every kinetic parameter examined to facilitate tighter binding of DNA and nucleotide and faster replication. The accessory protein makes the DNA binding 3.5-fold tighter (K(d) of 9.9 +/- 2.1 nM compared to 39 +/- 10 nM for the catalytic subunit alone) without significantly affecting the DNA dissociation rate (0.02 +/- 0.001 compared to 0.03 +/- 0.001 s(-)(1)). The ground-state nucleotide binding is improved from 4.7 +/- 2.0 to 0.78 +/- 0.065 microM, and the maximum DNA polymerization rate is increased from 8.7 +/- 1.1 to 45 +/- 1 s(-)(1) by the addition of the accessory protein. This leads to an increase in processivity from an estimated 290 +/- 46 to 2250 +/- 162. Although the accessory protein has been described as a "processivity factor" because of its effect on the ratio of rate constants defining processivity, this terminology falls short of adequately describing the profound effects of the small subunit on nucleotide-binding and incorporation catalyzed by the large subunit. By using the complete holoenzyme, we can now proceed with a comprehensive analysis of the structural and mechanistic determinants of enzyme specificity that govern toxicity of nucleoside analogues used in the treatment of viral infections such as AIDS.
我们从克隆并过表达的催化亚基和辅助亚基中重组了人线粒体DNA聚合酶全酶。我们检测了单独催化亚基和全酶的聚合活性,以确定辅助亚基在这种双亚基酶中的功能。通过其刺激最大DNA结合和聚合作用的浓度依赖性测定,辅助亚基与催化亚基结合的解离常数为35±16 nM。在饱和浓度下,辅助亚基对所检测的每个动力学参数都有贡献,有助于更紧密地结合DNA和核苷酸,并加快复制速度。辅助蛋白使DNA结合力提高了3.5倍(K(d)为9.9±2.1 nM,而单独催化亚基为39±10 nM),且不显著影响DNA解离速率(分别为0.02±0.001和0.03±0.001 s(-1))。通过添加辅助蛋白,基态核苷酸结合从4.7±2.0 μM提高到0.78±0.065 μM,最大DNA聚合速率从8.7±1.1提高到45±1 s(-1)。这导致持续合成能力从估计的290±46提高到2250±162。尽管辅助蛋白因其对定义持续合成能力的速率常数比值的影响而被描述为“持续合成能力因子”,但该术语不足以充分描述小亚基对大亚基催化的核苷酸结合和掺入的深远影响。通过使用完整的全酶,我们现在可以对酶特异性的结构和机制决定因素进行全面分析,这些决定因素控制着用于治疗艾滋病等病毒感染的核苷类似物的毒性。